Sen Thooran
1 Papers
Sen Thooran is an academic researcher. The author has contributed to research in topics: Internal medicine & Refractory (planetary science). The author has co-authored 1 publications.
Chat about Author
Papers
Low Dose Ruxolitinib in Indian Haplo-Identical Transplant Patients with Steroid Refractory Acute Graft Versus Host Disease
TL;DR: Zhao et al. as mentioned in this paper used a lower dose of 5mg per day Ruxolitinib for a period of minimum 60 days post-transplant to look into clinical benefit.